The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
The Leptin-Deficient (ob/ob) Mouse
Open accessAbstract
Whereas functional, metabolic, neurotrophic, and morphological abnormalities of peripheral diabetic neuropathy (PDN) have been extensively explored in streptozotocin-induced diabetic rats and mice (models of type 1 diabetes), insufficient information is available on manifestations and pathogenetic mechanisms of PDN in type 2 diabetic models. The latter could constitute a problem for clinical trial design because the vast majority of subjects with diabetes have type 2 (non–insulin dependent) diabetes. This study was aimed at characterization of PDN in leptin-deficient (ob/ob) mice, a model of type 2 diabetes with relatively mild hyperglycemia and obesity. ob/ob mice (∼11 weeks old) clearly developed manifest sciatic motor nerve conduction velocity (MNCV) and hind-limb digital sensory nerve conduction velocity (SNCV) deficits, thermal hypoalgesia, tactile allodynia, and a remarkable (∼78%) loss of intraepidermal nerve fibers. They also had increased sorbitol pathway activity in the sciatic nerve and increased nitrotyrosine and poly(ADP-ribose) immunofluorescence in the sciatic nerve, spinal cord, and dorsal root ganglion (DRG). Aldose reductase inhibition with fidarestat (16 mg · kg−1 · d−1), administered to ob/ob mice for 6 weeks starting from 5 weeks of age, was associated with preservation of normal MNCV and SNCV and alleviation of thermal hypoalgesia and intraepidermal nerve fiber loss but not tactile allodynia. Sciatic nerve nitrotyrosine immunofluorescence and the number of poly(ADP-ribose)–positive nuclei in sciatic nerve, spinal cord, and DRGs of fidarestat-treated ob/ob mice did not differ from those in nondiabetic controls. In conclusion, the leptin-deficient ob/ob mouse is a new animal model that develops both large motor and sensory fiber and small sensory fiber PDN and responds to pathogenetic treatment. The results support the role for increased aldose reductase activity in functional and structural changes of PDN in type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The spectrum of neuropathy in diabetes and impaired glucose tolerance
Sumner, C. J., Sheth, S., Griffin, J. W., Cornblath, D. R., & Polydefkis, M. (2003) · Neurology · doi:10.1212/wnl.60.1.108 · Cited by 708
Malik, R. A., Kallinikos, P., Abbott, C. A., van Schie, C. H. M., Morgan, P., Efron, N., & Boulton, A. J. M. (2003) · Diabetologia · doi:10.1007/s00125-003-1086-8 · Cited by 505
Becker, J., Nora, D. B., Gomes, I., Stringari, F. F., Seitensus, R., Panosso, J. S., & Ehlers, J. A. C. (2002) · Clinical Neurophysiology · doi:10.1016/s1388-2457(02)00201-8 · Cited by 395
The diabetic foot: from art to science. The 18th Camillo Golgi lecture
Boulton, A. J. M. (2004) · Diabetologia · doi:10.1007/s00125-004-1463-y · Cited by 370
Hotta, N., Akanuma, Y., Kawamori, R., Matsuoka, K., Oka, Y., Shichiri, M., Toyota, T., Nakashima, M., Yoshimura, I., Sakamoto, N., et al. (2006) · Diabetes Care · doi:10.2337/dc05-2370 · Cited by 366
Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments
Shun, C., Chang, Y., Wu, H., Hsieh, S., Lin, W., Lin, Y., Tai, T., & Hsieh, S. (2004) · Brain · doi:10.1093/brain/awh180 · Cited by 359
The Sensory Symptoms of Diabetic Polyneuropathy Are Improved With α-Lipoic Acid
The SYDNEY Trial Authors, F. T. S. T. S. G., Ametov, A. S., Barinov, A., Dyck, P. J., Hermann, R., Kozlova, N., Litchy, W. J., Low, P. A., Nehrdich, D., Novosadova, M., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.770 · Cited by 359
Diabetes-Obesity Syndromes in Mice
Coleman, D. L. (1982) · Diabetes · doi:10.2337/diab.31.1.s1 · Cited by 350
Diabetes in America, 2nd edition
Harris, M. I. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)90020-9 · Cited by 316
Insulin Resistance and Atherosclerosis
Nigro, J., Osman, N., Dart, A. M., & Little, P. J. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0007 · Cited by 314
Coppey, L. J., Gellett, J. S., Davidson, E. P., Dunlap, J. A., Lund, D. D., & Yorek, M. A. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1927 · Cited by 300
Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy
Greene, D. A., Arezzo, J. C., Brown, M. B., & the Zenarestat Study Group (1999) · Neurology · doi:10.1212/wnl.53.3.580 · Cited by 278
Pittenger, G. L., Ray, M., Burcus, N. I., McNulty, P., Basta, B., & Vinik, A. I. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.1974 · Cited by 263
Role of Poly(ADP-Ribose) Polymerase Activation in Diabetic Neuropathy
Obrosova, I. G., Li, F., Abatan, O. I., Forsell, M. A., Komjáti, K., Pacher, P., Szabó, C., & Stevens, M. J. (2004) · Diabetes · doi:10.2337/diabetes.53.3.711 · Cited by 236
Self-citationNakamura, J., Kato, K., Hamada, Y., Nakayama, M., Chaya, S., Nakashima, E., Naruse, K., Kasuya, Y., Mizubayashi, R., Miwa, K., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.10.2090 · Cited by 228
Leptin and its receptors: regulators of whole-body energy homeostasis
Houseknecht, K. L., & Portocarrero, C. P. (1998) · Domestic Animal Endocrinology · doi:10.1016/s0739-7240(98)00035-6 · Cited by 226
Hotta, N., Toyota, T., Matsuoka, K., Shigeta, Y., Kikkawa, R., Kaneko, T., Takahashi, A., Sugimura, K., Koike, Y., Ishii, J., et al. (2001) · Diabetes Care · doi:10.2337/diacare.24.10.1776 · Cited by 217
Obrosova, I. G., Huysen, C. V., Fathallah, L., Cao, X., Greene, D. A., & Stevens, M. J. (2002) · The FASEB Journal · doi:10.1096/fj.01-0603fje · Cited by 212
Self-citationStevens, M. J., Dananberg, J., Feldman, E. L., Lattimer, S. A., Kamijo, M., Thomas, T. P., Shindo, H., Sima, A. A., & Greene, D. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117406 · Cited by 208
Bastyr, E. J., Price, K. L., & Bril, V. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.08.002 · Cited by 202
Dyck, P. J., Dyck, P. J., Larson, T. S., O'Brien, P. C., & Velosa, J. A. (2000) · Diabetes Care · doi:10.2337/diacare.23.4.510 · Cited by 192
Obrosova, I. G., Pacher, P., Szabó, C., Zsengeller, Z., Hirooka, H., Stevens, M. J., & Yorek, M. A. (2005) · Diabetes · doi:10.2337/diabetes.54.1.234 · Cited by 178
Self-citationThe Sorbitol Pathway: Enzyme Localization and Content in Normal and Diabetic Nerve and Cord
Gabbay, K. H., & O'Sullivan, J. B. (1968) · Diabetes · doi:10.2337/diab.17.5.239 · Cited by 175
Sensory Neurons With Activated Caspase-3 Survive Long-Term Experimental Diabetes
Cheng, C., & Zochodne, D. W. (2003) · Diabetes · doi:10.2337/diabetes.52.9.2363 · Cited by 167
Quantitative measurement of cutaneous perception in diabetic neuropathy
Vinik, A. I., Suwanwalaikorn, S., Stansberry, K. B., Holland, M. T., McNitt, P. M., & Colen, L. E. (1995) · Muscle & Nerve · doi:10.1002/mus.880180603 · Cited by 162
Obesity and peripheral neuropathy risk: a dangerous liaison
Miscio, G., Guastamacchia, G., Brunani, A., Priano, L., Baudo, S., & Mauro, A. (2005) · Journal of the Peripheral Nervous System · doi:10.1111/j.1085-9489.2005.00047.x · Cited by 158
Obrosova, I. G., Mabley, J. G., Zsengellér, Z. K., Charniauskaya, T., Abatan, O. I., Groves, J. T., & Szabó, C. (2004) · The FASEB Journal · doi:10.1096/fj.04-1913fje · Cited by 157
Self-citationPotential mechanisms of neuropathic pain in diabetes
Calcutt, N. A. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)50078-7 · Cited by 154
Cameron, N. E., Cotter, M. A., Basso, M., & Hohman, T. C. (1997) · Diabetologia · doi:10.1007/s001250050674 · Cited by 154
Calcutt, N. A., Freshwater, J. D., & Mizisin, A. P. (2004) · Diabetologia · doi:10.1007/s00125-004-1354-2 · Cited by 148
Ho, E. C. M., Lam, K. S. L., Chen, Y. S., Yip, J. C. W., Arvindakshan, M., Yamagishi, S., Yagihashi, S., Oates, P. J., Ellery, C. A., Chung, S. S. M., et al. (2006) · Diabetes · doi:10.2337/db05-1497 · Cited by 148
Poly(ADP-Ribose) Polymerase Inhibition Alleviates Experimental Diabetic Sensory Neuropathy
Ilnytska, O., Lyzogubov, V. V., Stevens, M. J., Drel, V. R., Mashtalir, N., Pacher, P., Yorek, M. A., & Obrosova, I. G. (2006) · Diabetes · doi:10.2337/db06-0067 · Cited by 141
Self-citationImpact of Overweight on Chronic Microvascular Complications in Type 1 Diabetic Patients
Block, C. E. M. D., Leeuw, I. H. D., & Gaal, L. F. V. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1649 · Cited by 138
Malmberg, A. B., Mizisin, A. P., Calcutt, N. A., von Stein, T., Robbins, W. R., & Bley, K. R. (2004) · Pain · doi:10.1016/j.pain.2004.07.017 · Cited by 137
Oltman, C. L., Coppey, L. J., Gellett, J. S., Davidson, E. P., Lund, D. D., & Yorek, M. A. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00594.2004 · Cited by 131
Central role for aldose reductase pathway in myocardial ischemic injury
Hwang, Y. C., Kaneko, M., Bakr, S. A., Liao, H., Lu, Y., Lewis, E., Yan, S.-D., Ii, S., Itakura, M., Liu, R., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-1400com · Cited by 129
Bril, V., Buchanan, R. A., & the Ranirestat Study Group* (2006) · Diabetes Care · doi:10.2337/diacare.29.01.06.dc05-1447 · Cited by 128
Impaired glucose tolerance and insulinopenia in the GK‐rat causes peripheral neuropathy
Murakawa, Y., Zhang, W., Pierson, C. R., Brismar, T., Östenson, C., Efendić, S., & Sima, A. A. F. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.326 · Cited by 125
Price, S. A., Agthong, S., Middlemas, A., & Tomlinson, D. R. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1851 · Cited by 122
Small fiber neuropathy is associated with the metabolic syndrome
Pittenger, G. L., Mehrabyan, A., Simmons, K., Amandarice, Dublin, C., Barlow, P., & Vinik, A. I. (2005) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2005.3.113 · Cited by 116
Cameron, N. E., Tuck, Z., McCabe, L., & Cotter, M. A. (2001) · Diabetologia · doi:10.1007/s001250100626 · Cited by 97
Therapeutic efficacy of sonic hedgehog protein in experimental diabetic neuropathy
Calcutt, N. A., Allendoerfer, K. L., Mizisin, A. P., Middlemas, A., Freshwater, J. D., Burgers, M. L., Ranciato, R., Delcroix, J., Taylor, F. R., Shapiro, R. I., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200315792 · Cited by 93
Taurine reverses neurological and neurovascular deficits in Zucker diabetic fatty rats
Li, F., Abatan, O. I., Kim, H. S., Burnett, D., Larkin, D. D., Obrosova, I. G., & Stevens, M. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.012 · Cited by 85
Self-citationUnmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes
Kamiya, H., Murakawa, Y., Zhang, W., & Sima, A. A. F. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.541 · Cited by 77
Diemel, L. T., Stevens, E. J., Willars, G. B., & Tomlinson, D. R. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90416-5 · Cited by 75
Obrosova, I. G., Fathallah, L., Lang, H., & Greene, D. A. (1999) · Diabetologia · doi:10.1007/s001250051290 · Cited by 72
Self-citationPolyneuropathy with impaired glucose tolerance: Implications for diagnosis and therapy
Singleton, J. R., Smith, A. G., Russell, J. W., & Feldman, E. L. (2005) · Current Treatment Options in Neurology · doi:10.1007/s11940-005-0004-4 · Cited by 62
Kato, N., Mizuno, K., Makino, M., Suzuki, T., & Yagihashi, S. (2000) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(00)00164-9 · Cited by 58
Obrosova, I. G., Huysen, C. V., Fathallah, L., Cao, X., Stevens, M. J., & Greene, D. A. (2000) · The FASEB Journal · doi:10.1096/fj.99-0803com · Cited by 54
Self-citationOhi, T., Saita, K., Furukawa, S., Ohta, M., HAYASHI, K., & Matsukura, S. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6821 · Cited by 41
Kuruvilla, R., & Eichberg, J. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71020775.x · Cited by 32
Polyol pathway inhibition improves age‐related vascular dysfunction in rats
Hallam, K. M., Gomez, T., Li, Q., Ananthakrishnan, R., Yan, S. F., Schmidt, A. M., & Ramasamy, R. (2006) · The FASEB Journal · doi:10.1096/fasebj.20.4.a721-c · Cited by 6
Cited by
Baron, M., Veres, A., Wolock, S. L., Faust, A. L., Gaujoux, R., Vetere, A., Ryu, J. H., Wagner, B. K., Shen-Orr, S. S., Klein, A. M., et al. (2016) · Cell Systems · doi:10.1016/j.cels.2016.08.011 · Cited by 1,508
Anti-inflammatory activity of natural dietary flavonoids
Pan, M.-H., Lai, C.-S., & Ho, C.-T. (2010) · Food & Function · doi:10.1039/c0fo00103a · Cited by 605
Leptin- and Leptin Receptor-Deficient Rodent Models: Relevance for Human Type 2 Diabetes
Wang, B., Chandrasekera, P., & Pippin, J. (2014) · Current Diabetes Reviews · doi:10.2174/1573399810666140508121012 · Cited by 506
Mechanism of diabetic neuropathy: Where are we now and where to go?
Yagihashi, S., Mizukami, H., & Sugimoto, K. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00070.x · Cited by 488
Animal models of neuropathic pain
Jaggi, A. S., Jain, V., & Singh, N. (2011) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2009.00801.x · Cited by 387
Metadata
- Authors
- Drel, V. R., Mashtalir, N., Ilnytska, O., Shin, J., Li, F., Lyzogubov, V. V., & Obrosova, I. G.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2006-12-01
- Volume
- 55
- Issue
- 12
- Pages
- 3335-3343
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2099905857
- Cited by
- 264
- References
- 52
- FWCI
- 7.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.